Skip to main content.

Jo A. Wick, PhD

Jo Wick portrait
Associate Professor, Biostatistics & Data Science
jwick@kumc.edu

Professional Background

Dr. Wick has more than a decade of education and experience in biostatistics, clinical trial design and analysis, Bayesian statistics, and adaptive clinical trials. Her methodological and collaborative research focuses on issues in clinical trial design, Bayesian methodology, and statistics education. She has experience in clinical and pre-clinical research environments in areas including benefit-risk analysis, response-adaptive clinical trial design, Bayesian trial design, and secondary data analysis. Dr. Wick's translational expertise is in the areas of respiratory-, cancer-, and heart failure-interventions and outcomes, health disparities, and clinical trials.

Education and Training
  • PhD, Statistics, Baylor Univ., Waco, Texas

Publications
  • Wick, Jo., A, Yeh, Hung-Wen, Gajewski, Byron., J. 2017. A Bayesian analysis of synchronous distance learning versus matched traditional control in graduate biostatistics courses. The American Statistician, 71 (2), 137--144
  • Jiang, Y, Boyle, D., K, Bott, M., J, Wick, J., A, Yu, Q, Gajewski, B., J. 2014. Expediting Clinical and Translational Research via Bayesian Instrument Development.. Applied psychological measurement, 38 (4), 296-310
  • Mudaranthakam, Dinesh., Pal, Cernik, Colin, Curtis, Leslie, Griffith, Blake, Hu, Jinxiang, Wick, Jo, Thompson, Jeffrey, Gajewski, Byron, Koestler, Devin, Jensen, Roy., A, others. 2020. Utilization of Technology to Improve Efficiency in Investigational Drug Management Processes. Journal of Pharmacy Technology, 36 (2), 84--90. https://journals.sagepub.com/doi/abs/10.1177/8755122519900049?journalCode=pmta
  • Williamson, S., K, Johnson, G., A, Maulhardt, H., A, Moore, K., M, McMeekin, D., S, Schulz, T., K, Reed, G., A, Roby, K., F, Mackay, C., B, Smith, H., J, Weir, S., J, Wick, J., A, Markman, M, diZerega, G., S, Baltezor, M., J, Espinosa, J, Decedue, C., J. 2015. A phase I study of intraperitoneal nanoparticulate paclitaxel (Nanotax®) in patients with peritoneal malignancies.. Cancer chemotherapy and pharmacology, 75 (5), 1075-87
  • Smith, C., E, Piamjariyakul, U, Wick, J., A, Spertus, J., A, Russell, C, Dalton, K., M, Elyachar, A, Vacek, J., L, Reeder, K., M, Nazir, N, Ellerbeck, E., F. 2014. Multidisciplinary group clinic appointments: the Self-Management and Care of Heart Failure (SMAC-HF) trial.. Circulation. Heart failure, 7 (6), 888-94